Respiratory syncytial virus outbreaks are predicted after the COVID-19 pandemic in Tokyo, Japan

Lina Madaniyazi; Xerxes Seposo; Chris Fook Sheng Ng; Aurelio Tobias; Michiko Toizumi; Hiroyuki Moriuchi; Lay-Myint Yoshida; Masahiro Hashizume

doi:10.7883/yoken.JJID.2021.312

This article has now been updated. Please use the final version.

Respiratory syncytial virus outbreaks are predicted after the COVID-19 pandemic in Tokyo, Japan

Lina Madaniyazi, Xerxes Seposo, Chris Fook Sheng Ng, Aurelio Tobias, Michiko Toizumi, Hiroyuki Moriuchi, Lay-Myint Yoshida, Masahiro Hashizume

Author information

Lina Madaniyazi
Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Japan
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Xerxes Seposo
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Chris Fook Sheng Ng
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Aurelio Tobias
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Institute of Environmental Assessment and Water Research (IDAEA), Spanish Council for Scientific Research (CSIC), Spain
Michiko Toizumi
Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Japan
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Hiroyuki Moriuchi
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Department of Pediatrics, Graduate School of Biomedical Sciences, Nagasaki University, Japan
Lay-Myint Yoshida
Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Japan
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Masahiro Hashizume
Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Japan
School of Tropical Medicine and Global Health, Nagasaki University, Japan
Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Japan

Keywords: respiratory syncytial virus, nonpharmaceutical interventions, COVID-19

JOURNAL FREE ACCESS Advance online publication

Article ID: JJID.2021.312

DOI https://doi.org/10.7883/yoken.JJID.2021.312

The final version of this article is now available: Vol. 75 (2022), No. 2 pp. 209-211

Details

Abstract

The nonpharmaceutical interventions (NPIs) on COVID-19 can impact current and future dynamics of respiratory syncytial virus infections (RSV). In Tokyo, RSV activity declined by 97.9% (95%CI: 94.8% - 99.2%) during NPIs. A longer period of NPIs could expand susceptible populations, enhancing the potential for larger RSV outbreaks after NPIs ends.

Corresponding author

Register with J-STAGE for free!